This training module is meant to strengthen the capacity of CHVs to prevent the Non Communicable Diseases at the community level . The Government of Kenya is committed to supporting community health initiatives and accelerating the achievem...ent of the KHSS&IP goals, Millennium Development Goals (MDGs) and providing support to Vision 203
more
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...tandardised questionnaires and the Global TB Drug Facility website.
more
The achievable imperative for global progress
Up-to-date Literature review current through: Jan 2015. | This topic last updated: Jan 29, 2015.
Ghana Med J. 2012 Jun;46(2 Suppl):69-78.
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
РУКОВОДСТВО ДЛЯ АКТИВИСТОВ ПО ИНСТРУМЕНТАМ ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА ЯНВАРЬ.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
International Journal of Infectious Diseases 32 (2015) 111–117